EID3 overexpression not only improved stem cell phenotype but also enhanced the enrichment of CD133+ cells and the expression of stem cell-related markers OCT3/4, ABCG2, and NANOG in osteosarcoma cells [14]. This evidence concerns the gene ABCG2 and osteosarcoma.